Search This Blog

Thursday, August 1, 2019

DBV Technologies reports 1H results

DBV Technologies (NASDAQ:DBVT): 1H GAAP EPS of -€2.43.
Cash and equivalents of €107.3M

Valneva SE reports 1H results

Valneva SE (OTC:INRLF): 1H net loss of €2.4M
Revenue of €54.5M (-7.6% Y/Y)

SmileDirectClub aims for IPO in September

Looking to sell up to $1B in stock, SmileDirectClub is currently on file confidentially and aiming to flip its IPO prospectus to be public sometime next month, with a debut targeted for September.
SmileDirectClub was most recently valued at $3.2B in a private fundraising round led by Clayton, Dubilier & Rice, Kleiner Perkins and Spark Capital.
The company competes with Align Technology (NASDAQ:ALGN), the publicly traded maker of Invisalign, which acquired a 17% stake in SmileDirectClub in 2016. Since then, the two have feuded.

Mednax EPS beats by $0.02, revenue in-line

Mednax (NYSE:MD): Q2 Non-GAAP EPS of $0.89 beats by $0.02; GAAP EPS of $0.42 misses by $0.22.
Revenue of $868.31M (+0.4% Y/Y) in-line.

Cigna up 3% premarket on Q2 beat; 2019 guidance raised

Cigna (CIQ2 results: Revenues: $34,375M (+198.9%).
Net Income: $1,408M (+74.7%); EPS: $3.70 (+12.5%); Non-GAAP Net Income: $1,640M (+71.7%); Non-GAAP EPS: $4.30 (+10.5%).
Total medical care ratio of 81.6% in Q2.
2019 Guidance: non-GAAP Revenue: $136B – 137B from $132.5B – 134.5B; non-GAAP Net Income: $6.34B – 6.46B from $6.24B – 6.4B; non-GAAP EPS: $16.60 – 16.90 from $16.25 – 16.65; Medical Care Ratio: 80.5% – 81.5% (unch).
Shares are up 3% premarket.

Agios Pharmaceuticals EPS misses by $0.15, misses on revenue

Agios Pharmaceuticals (NASDAQ:AGIO): Q2 GAAP EPS of -$1.87 misses by $0.15.
Revenue of $26.22M (-35.1% Y/Y) misses by $0.83M.

Akorn EPS beats by $0.05, beats on revenue

Akorn (NASDAQ:AKRX): Q2 Non-GAAP EPS of -$0.02 beats by $0.05; GAAP EPS of -$0.89 misses by $0.59.
Revenue of $178.06M (-6.7% Y/Y) beats by $6.09M.